BIT 4.76% 2.2¢ biotron limited

I think the answer to this question will be better determined...

  1. 1,917 Posts.
    lightbulb Created with Sketch. 1324
    I think the answer to this question will be better determined after the March conference. If the data from the second trial is as good as we all hope and MM/BIT are trill struggling for a partner, then IMO a restructure will be required. An individual with a strong proven commercial background would be better suited a that point to partner the company with a large pharma. Time will tell..
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.